Search results
Results From The WOW.Com Content Network
Leukoplakia is a firmly attached white patch on a mucous membrane which is associated with increased risk of cancer. [4] [5] The edges of the lesion are typically abrupt and the lesion changes with time. [4] [6] Advanced forms may develop red patches. [6] There are generally no other symptoms. [9]
Cancer mortality rates are determined by the relationship of a population's health and lifestyle with their healthcare system. In the United States during 2013–2017, the age-adjusted mortality rate for all types of cancer was 189.5/100,000 for males, and 135.7/100,000 for females. [ 1 ]
The most common cancer among women in the United States is breast cancer (123.7 per 100,000), followed by lung cancer (51.5 per 100,000) and colorectal cancer (33.6 per 100,000), but lung cancer surpasses breast cancer as the leading cause of cancer death among women. [13]
Oral cancer has an overall 5 year survival rate of 65% in the United States as of 2015. [4] This varies from 84% if diagnosed when localized, compared to 66% if it has spread to the lymph nodes in the neck, and 39% if it has spread to distant parts of the body. [4] Survival rates also are dependent on the location of the disease in the mouth. [16]
Dyskeratosis congenita (DKC), also known as Zinsser-Engman-Cole syndrome, is a rare progressive congenital disorder with a highly variable phenotype. [3] The entity was classically defined by the triad of abnormal skin pigmentation, nail dystrophy, and leukoplakia of the oral mucosa, and myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML), but these components do not always occur. [3]
If the coding was accurate, this figure should approximate 1.0 as the rate of those dying of non-cancer deaths (in a population of cancer sufferers) should approximate that of the general population. Thus, the use of relative survival provides an accurate way to measure survival rates that are associated with the cancer in question.
Five-year relative survival rates describe the percentage of patients with a disease alive five years after the disease is diagnosed, divided by the percentage of the general population of corresponding sex and age alive after five years. Typically, cancer five-year relative survival rates are well below 100%, reflecting excess mortality among ...
median overall survival time of approximately 12–16 months, with five-year survival rate of approximately 26% and the long-term survival rate of approximately 4 - 5%. Limited-stage small cell lung carcinoma (LS-SCLC) is a type of small cell lung cancer (SCLC) that is confined to an area which is small enough to be encompassed within a ...